Advanced search
Publication Cover
Expert Review of Hematology Volume 12, 2019 - Issue 9
Submit an article Journal homepage
1,105
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Towards the integration of patient-reported outcomes into the global clinical management of multiple myeloma

Pasquale NiscolaHematology Unit, Sant’Eugenio Hospital, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2226-6518View further author information
ORCID Icon,
Laura ScaramucciHematology Unit, Sant’Eugenio Hospital, Rome, ItalyView further author information
&
Fabio EfficaceData Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, ItalyView further author information
Pages 703-705 | Received 09 Apr 2019, Accepted 15 Jul 2019, Published online: 28 Aug 2019

References

  • Genadieva Stavric S, Bonello F, Bringhen S, et al. How is patient care for multiple myeloma advancing? Expert Rev Hematol. 2017;10:551–561.
  • Goldschmidt H, Ashcroft J, Szabo Z, et al. Navigating the treatment landscape in multiple myeloma: which combinations to use and when? Ann Hematol. 2019;98:1–18.
  • Palumbo A, Bringhen S, Mateos MV, et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood. 2015;125:2068–2074.
  • Despiegel N, Touboul C, Flinois A, et al. Health-related quality of life of patients with multiple myeloma treated in routine clinical practice in France. Clin Lymphoma Myeloma Leuk. 2019;19:e13–e28.
  • Ramsenthaler C, Osborne TR, Gao W, et al. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer. 2016;16:427.
  • Maes H, Delforge M. Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations. Expert Rev Hematol. 2015;8:355–366.
  • Osborne TR, Ramsenthaler C, Siegert RJ, et al. What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. Eur J Haematol. 2012;89:437–457.
  • Delforge M, Ludwig H. How I manage the toxicities of myeloma drugs. Blood. 2017;129:2359–2367.
  • Wagner LI, Robinson D Jr., Weiss M, et al. Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction. J Pain Symptom Manage. 2012;43:1094–1104.
  • Efficace F, Gaidano G, Lo-Coco F. Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice? Blood. 2017;130:859–866.
  • Seitzler S, Finley-Oliver E, Simonelli C, et al. Quality of life in multiple myeloma: considerations and recommendations. Expert Rev Hematol. 2019 Jun;12(6):419–424.
  • Cocks K, Cohen D, Wisloff F, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer. 2007;43:1670–1678.
  • Ahmedzai SH, Snowden JA, Ashcroft AJ, et al. Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. J Clin Oncol. 2019 Apr 10;37:1617–1628. Epub ahead of print.
  • Cook G, Ashcroft AJ, Cairns DA, et al. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF myeloma X relapse [Intensive]): a randomised, open-label, phase 3 trial. Lancet Haematol. 2016 Jul;3(7):e340–51.
  • Sparano F, Cavo M, Niscola P, et al. Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review. Support Care Cancer. 2018;26:2075–2090.
  • Di Maio M, Basch E, Bryce J, et al. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat Rev Clin Oncol. 2016;13:319–325.
  • Nielsen LK, Klausen TW, Jarden M, et al. Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients. Eur J Haematol. 2019;102:70–78.
  • Kumar SK, Vij R, Noga SJ, et al. Treating multiple myeloma patients with oral therapies. Clin Lymphoma Myeloma Leuk. 2017;17:243–251.
  • Basch E, Barbera L, Kerrigan CL, et al. Implementation of patient-reported outcomes in routine medical care. Am Soc Clin Oncol Educ Book. 2018;122–134.
  • Bennett AV, Jensen RE, Basch E. Electronic patient-reported outcome systems in oncology clinical practice. CA Cancer J Clin. 2012;62:337–347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.